"Insights Into Treatment-Resistant Depression: Current And Emerging Therapies"
Depression is the number one cause of medical disability in the world, partially because it is relatively common. Unlike many significant medical diseases like cardiovascular disease and diabetes that tend to affect older individuals, major depression tends to affect young individuals at a vulnerable time when they are establishing their identity, going to school, or trying to start relationships or families. “A lot of new research now is focused on trying to understand whether some of these signaling pathways like glutamate or gamma-aminobutyric acid could be a way to treat depression,” said James Murrough, MD, assistant professor of psychiatry, neuroscience, and director of the mood and anxiety disorders program at the Icahn School of Medicine at Mount Sinai.
- James Murrough, MD, Assistant Professor, Psychiatry, Neuroscience, Director, Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai